{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:39:49Z","timestamp":1792676389554,"version":"4.5.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Botulinum toxin and dermal filler injections are the most commonly performed minimally invasive cosmetic procedures in the United States. These injectables require extensive medical training, experience, and oversight to be administered safely due to risk of significant complications. However, rules and regulations governing their administration differ widely across states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To summarize the legal statutes, regulations, codes, and professional guidelines governing administration of botulinum toxin and dermal filler injections in the United States using sources from legal databases, scholarly search engines, state government websites, and the American Society for Dermatologic Surgery Association (ASDSA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>WestLaw, LexisNexis, PubMed, Google Scholar, and state government websites were searched using key terms. ASDSA Patient Safety Resources and referenced source materials were examined for each state and the District of Columbia. Relevant material from January 1, 2000 to December 31, 2024 published in English was recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Substantial variability exists among states in scope of practice restrictions, medical supervision, and oversight requirements for cosmetic injectables. Several states have no specific regulations in this area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Inconsistent or absent state regulations may jeopardize patient safety. The technical skill and potential risks associated with cosmetic injectables warrants consistent national standards surrounding their administration. Significant state-to-state variation in provider scope of practice supervision requirements highlights the need for clear, consistent legislation that clarifies provider roles, establishes minimum competency standards, and prioritizes patient safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000005384","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:00:28Z","timestamp":1792674028000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Botulinum Toxin and Dermal Filler: Discordant Legislation, Regulations, and Guidelines in the United States"],"prefix":"10.1097","author":[{"given":"Amanda M.","family":"Ferrante","sequence":"first","affiliation":[{"name":"All authors are affiliated with the Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Laurin","family":"Council","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basia M.","family":"Michalski-McNeely","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"R2-20261022","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3390\/diagnostics14151640","article-title":"Review of the adverse effects associated with dermal filler treatments: part I nodules, granuloma, and migration","volume":"14","author":"Hong","year":"2024","journal-title":"Diagnostics"},{"key":"R3-20261022","doi-asserted-by":"crossref","first-page":"853","DOI":"10.5114\/ada.2019.82795","article-title":"The whole truth about botulinum toxin - a review","volume":"37","author":"Witmanowski","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"R4-20261022","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/DSS.0000000000001829","article-title":"Nonphysician practice of cosmetic dermatology: a patient and physician perspective of outcomes and adverse events","volume":"45","author":"Rossi","year":"2019","journal-title":"Dermatol Surg"},{"key":"R5-20261022","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/DSS.0000000000004648","article-title":"Medical Spa Legislation, Regulations, and Guidelines in the United States","volume":"51","author":"Malik","year":"2025","journal-title":"Dermatol Surg"},{"key":"R18-20261022","article-title":"Title 4: professions and occupations, chapter 11: state board of dental examiners, Article 6: Dental Hygienists","year":"2024","journal-title":"Ariz Administrative Regist"},{"key":"R23-20261022","article-title":"Use of Mid-level practitioners For laser, dermabrators, Botox, and other treatments","year":"2006","journal-title":"Medical Board of California"},{"key":"R27-20261022","article-title":"Rule 800 \u2013 delegation and supervision of medical services to unlicensed health care providers pursuant to section 12-36-106(3)(I), C.R.S. 3 CCR 713-30","year":"2011","journal-title":"Colorado Medical Board"},{"key":"R34-20261022","year":"2014","journal-title":"District of Columbia Department of Health Health Regulation and Licensing Administration Board of Medicine"},{"key":"R35-20261022","journal-title":"LexisNexis"},{"key":"R45-20261022","article-title":"Administration of injectable pharmacologics","journal-title":"WestLaw"},{"key":"R48-20261022"},{"key":"R49-20261022","article-title":"01.04 - rules of the board of medicine for registration of supervising & directing physicians","year":"2007","journal-title":"Idaho Board of Medicine"},{"key":"R51-20261022","year":"2024","journal-title":"Idaho State Board of Medicine"},{"key":"R57-20261022","year":"2004","journal-title":"Am Soc Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DSS.0000000000005384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:00:29Z","timestamp":1792674029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DSS.0000000000005384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000005384","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}